Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, January 1999, p. 14-19, Vol. 6, No. 1
Department of
Epidemiology1 and
Department of
Molecular Microbiology and Immunology,2
Johns Hopkins School of Public Health, Baltimore, Maryland;
Departments of Pathology and Microbiology, University
of Pittsburgh Graduate School of Public Health, Pittsburgh,
Pennsylvania3;
Department of Medicine,
Northwestern University School of Medicine and the Howard Brown
Health Center, Chicago, Illinois4; and
Department of Medicine and Jonsson Comprehensive
Cancer Center, University of California School of Medicine, Los
Angeles, California5
Received 22 June 1998/Returned for modification 11 August
1998/Accepted 12 October 1998
The Multicenter AIDS Cohort Study (MACS), an ongoing prospective
study of the natural history of human immunodeficiency virus (HIV), has
stored biologic specimens, including peripheral blood mononuclear cells
(PBMC), from 5,622 participants for up to 12 years. The purpose of the
present analysis was to evaluate the quality of the PBMC in the MACS
repository in order to test the validity and feasibility of nested
retrospective studies and to guide the planning of future repositories.
PBMC were collected from MACS participants at four centers at 6-month
intervals from 1984 to 1995, cryopreserved, and transported to a
central repository for storage. A total of 596 of these specimens were
subsequently tested for viability and used to evaluate cell function,
to conduct immunophenotype analysis, or to isolate HIV. Simple linear
regression models were applied to evaluate trends in recovery and
viability over time and by center. Results indicated that from a
nominal 107 cells cryopreserved per vial at all four
centers, the median number of viable cells recovered was at least
5 × 106 (50% of the number stored) and the median
viability was at least 90%. Results suggested that cryopreserved cells
can be stored for at least 12 years with no general tendency toward
cell loss over time. Furthermore, there were no statistically
significant changes in the percent cell viability according to the
length of time frozen, regardless of HIV serostatus or the level of
CD4+ lymphocytes. Storing 107 PBMC per vial
yields sufficient viable cells for phenotypic and/or functional
analysis. Results from the MACS provide the basis for the planning of
future repositories for use by investigators with similar research goals.
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Viability and Recovery of Peripheral Blood
Mononuclear Cells Cryopreserved for up to 12 Years in a
Multicenter Study
*
Corresponding author. Mailing address: Johns Hopkins
School of Public Health, Department of Epidemiology, 615 N. Wolfe St., Baltimore, MD 21205. Phone: (410) 955-4320. Fax: (410) 955-7587. E-mail: ckleeber{at}jhsph.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |